The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biopharma Outsourcing-Global Market Insights and Sales Trends 2025
Synopsis
Biopharma outsourcing plays an important role in the growth of biopharmaceuticals market. The growth of this market is promising with rapidly expanding biosimilars base.
The global Biopharma Outsourcing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biopharma Outsourcing in various end use industries. The expanding demands from the Drug Discovery, Clinical Trials, Preclinical Development and Biology Research, are propelling Biopharma Outsourcing market. Raw Material Sourcing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Active Pharmaceutical Ingredient segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biopharma Outsourcing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biopharma Outsourcing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biopharma Outsourcing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biopharma Outsourcing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biopharma Outsourcing covered in this report include Sartorius, Emcure Pharmaceuticals, BioPharma Services, Lambda Therapeutic Research, Baxter Healthcare, Keyrus Biopharma, Quintiles, Aptuit and KBI Biopharm, etc.
The global Biopharma Outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sartorius
Emcure Pharmaceuticals
BioPharma Services
Lambda Therapeutic Research
Baxter Healthcare
Keyrus Biopharma
Quintiles
Aptuit
KBI Biopharm
ICON
Global Biopharma Outsourcing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biopharma Outsourcing market, Segment by Type:
Raw Material Sourcing
Active Pharmaceutical Ingredient
Finished Drugs
Global Biopharma Outsourcing market, by Application
Drug Discovery
Clinical Trials
Preclinical Development
Biology Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biopharma Outsourcing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Biopharma outsourcing plays an important role in the growth of biopharmaceuticals market. The growth of this market is promising with rapidly expanding biosimilars base.
The global Biopharma Outsourcing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biopharma Outsourcing in various end use industries. The expanding demands from the Drug Discovery, Clinical Trials, Preclinical Development and Biology Research, are propelling Biopharma Outsourcing market. Raw Material Sourcing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Active Pharmaceutical Ingredient segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biopharma Outsourcing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biopharma Outsourcing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biopharma Outsourcing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biopharma Outsourcing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biopharma Outsourcing covered in this report include Sartorius, Emcure Pharmaceuticals, BioPharma Services, Lambda Therapeutic Research, Baxter Healthcare, Keyrus Biopharma, Quintiles, Aptuit and KBI Biopharm, etc.
The global Biopharma Outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sartorius
Emcure Pharmaceuticals
BioPharma Services
Lambda Therapeutic Research
Baxter Healthcare
Keyrus Biopharma
Quintiles
Aptuit
KBI Biopharm
ICON
Global Biopharma Outsourcing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biopharma Outsourcing market, Segment by Type:
Raw Material Sourcing
Active Pharmaceutical Ingredient
Finished Drugs
Global Biopharma Outsourcing market, by Application
Drug Discovery
Clinical Trials
Preclinical Development
Biology Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biopharma Outsourcing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biopharma Outsourcing
1.1 Biopharma Outsourcing Market Overview
1.1.1 Biopharma Outsourcing Product Scope
1.1.2 Biopharma Outsourcing Market Status and Outlook
1.2 Global Biopharma Outsourcing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biopharma Outsourcing Market Size by Region (2018-2029)
1.4 Global Biopharma Outsourcing Historic Market Size by Region (2018-2023)
1.5 Global Biopharma Outsourcing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biopharma Outsourcing Market Size (2018-2029)
1.6.1 North America Biopharma Outsourcing Market Size (2018-2029)
1.6.2 Europe Biopharma Outsourcing Market Size (2018-2029)
1.6.3 Asia-Pacific Biopharma Outsourcing Market Size (2018-2029)
1.6.4 Latin America Biopharma Outsourcing Market Size (2018-2029)
1.6.5 Middle East & Africa Biopharma Outsourcing Market Size (2018-2029)
2 Biopharma Outsourcing Market by Type
2.1 Introduction
2.1.1 Raw Material Sourcing
2.1.2 Active Pharmaceutical Ingredient
2.1.3 Finished Drugs
2.2 Global Biopharma Outsourcing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biopharma Outsourcing Historic Market Size by Type (2018-2023)
2.2.2 Global Biopharma Outsourcing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biopharma Outsourcing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biopharma Outsourcing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biopharma Outsourcing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biopharma Outsourcing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biopharma Outsourcing Revenue Breakdown by Type (2018-2029)
3 Biopharma Outsourcing Market Overview by Application
3.1 Introduction
3.1.1 Drug Discovery
3.1.2 Clinical Trials
3.1.3 Preclinical Development
3.1.4 Biology Research
3.2 Global Biopharma Outsourcing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biopharma Outsourcing Historic Market Size by Application (2018-2023)
3.2.2 Global Biopharma Outsourcing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biopharma Outsourcing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biopharma Outsourcing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biopharma Outsourcing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biopharma Outsourcing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biopharma Outsourcing Revenue Breakdown by Application (2018-2029)
4 Biopharma Outsourcing Competition Analysis by Players
4.1 Global Biopharma Outsourcing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biopharma Outsourcing as of 2022)
4.3 Date of Key Players Enter into Biopharma Outsourcing Market
4.4 Global Top Players Biopharma Outsourcing Headquarters and Area Served
4.5 Key Players Biopharma Outsourcing Product Solution and Service
4.6 Competitive Status
4.6.1 Biopharma Outsourcing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sartorius
5.1.1 Sartorius Profile
5.1.2 Sartorius Main Business
5.1.3 Sartorius Biopharma Outsourcing Products, Services and Solutions
5.1.4 Sartorius Biopharma Outsourcing Revenue (US$ Million) & (2018-2023)
5.1.5 Sartorius Recent Developments
5.2 Emcure Pharmaceuticals
5.2.1 Emcure Pharmaceuticals Profile
5.2.2 Emcure Pharmaceuticals Main Business
5.2.3 Emcure Pharmaceuticals Biopharma Outsourcing Products, Services and Solutions
5.2.4 Emcure Pharmaceuticals Biopharma Outsourcing Revenue (US$ Million) & (2018-2023)
5.2.5 Emcure Pharmaceuticals Recent Developments
5.3 BioPharma Services
5.3.1 BioPharma Services Profile
5.3.2 BioPharma Services Main Business
5.3.3 BioPharma Services Biopharma Outsourcing Products, Services and Solutions
5.3.4 BioPharma Services Biopharma Outsourcing Revenue (US$ Million) & (2018-2023)
5.3.5 Lambda Therapeutic Research Recent Developments
5.4 Lambda Therapeutic Research
5.4.1 Lambda Therapeutic Research Profile
5.4.2 Lambda Therapeutic Research Main Business
5.4.3 Lambda Therapeutic Research Biopharma Outsourcing Products, Services and Solutions
5.4.4 Lambda Therapeutic Research Biopharma Outsourcing Revenue (US$ Million) & (2018-2023)
5.4.5 Lambda Therapeutic Research Recent Developments
5.5 Baxter Healthcare
5.5.1 Baxter Healthcare Profile
5.5.2 Baxter Healthcare Main Business
5.5.3 Baxter Healthcare Biopharma Outsourcing Products, Services and Solutions
5.5.4 Baxter Healthcare Biopharma Outsourcing Revenue (US$ Million) & (2018-2023)
5.5.5 Baxter Healthcare Recent Developments
5.6 Keyrus Biopharma
5.6.1 Keyrus Biopharma Profile
5.6.2 Keyrus Biopharma Main Business
5.6.3 Keyrus Biopharma Biopharma Outsourcing Products, Services and Solutions
5.6.4 Keyrus Biopharma Biopharma Outsourcing Revenue (US$ Million) & (2018-2023)
5.6.5 Keyrus Biopharma Recent Developments
5.7 Quintiles
5.7.1 Quintiles Profile
5.7.2 Quintiles Main Business
5.7.3 Quintiles Biopharma Outsourcing Products, Services and Solutions
5.7.4 Quintiles Biopharma Outsourcing Revenue (US$ Million) & (2018-2023)
5.7.5 Quintiles Recent Developments
5.8 Aptuit
5.8.1 Aptuit Profile
5.8.2 Aptuit Main Business
5.8.3 Aptuit Biopharma Outsourcing Products, Services and Solutions
5.8.4 Aptuit Biopharma Outsourcing Revenue (US$ Million) & (2018-2023)
5.8.5 Aptuit Recent Developments
5.9 KBI Biopharm
5.9.1 KBI Biopharm Profile
5.9.2 KBI Biopharm Main Business
5.9.3 KBI Biopharm Biopharma Outsourcing Products, Services and Solutions
5.9.4 KBI Biopharm Biopharma Outsourcing Revenue (US$ Million) & (2018-2023)
5.9.5 KBI Biopharm Recent Developments
5.10 ICON
5.10.1 ICON Profile
5.10.2 ICON Main Business
5.10.3 ICON Biopharma Outsourcing Products, Services and Solutions
5.10.4 ICON Biopharma Outsourcing Revenue (US$ Million) & (2018-2023)
5.10.5 ICON Recent Developments
6 North America
6.1 North America Biopharma Outsourcing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Biopharma Outsourcing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biopharma Outsourcing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biopharma Outsourcing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biopharma Outsourcing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biopharma Outsourcing Market Dynamics
11.1 Biopharma Outsourcing Industry Trends
11.2 Biopharma Outsourcing Market Drivers
11.3 Biopharma Outsourcing Market Challenges
11.4 Biopharma Outsourcing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
